StockNews.com initiated coverage on shares of Oragenics (NYSE:OGEN – Free Report) in a research note published on Monday. The brokerage issued a sell rating on the stock.
Oragenics Stock Performance
OGEN opened at $0.28 on Monday. The stock’s 50 day moving average price is $0.32 and its 200-day moving average price is $0.46. Oragenics has a one year low of $0.25 and a one year high of $3.43. The stock has a market cap of $3.42 million, a price-to-earnings ratio of -0.04 and a beta of 0.38.
Oragenics Company Profile
See Also
- Five stocks we like better than Oragenics
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Buffett’s on the Sidelines – Should You Follow?
- Best Aerospace Stocks Investing
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Oragenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oragenics and related companies with MarketBeat.com's FREE daily email newsletter.